Primary oesophageal involvement by lymphoma in two patients, one with Hodgkin's disease and one with non-Hodgkin's lymphoma is reported. In both, there were no manifestations of the disease outside the oesophagus, which is exceptionaily rare. In the patient with non-Hodgkin's lymphoma, the oesophageal tumour was the first manifestation of lymphoma. Shortly after admission he developed a tracheo-oesophageal fistula from which he died before treatment could be started. In the patient with Hodgkin's disease, isolated oesophageal lymphoma was the first relapse after a 13 year interval free of disease.
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As he had previously received mediastinal irradiation he was treated with combination chemotherapy that resulted in long term survival (>five years). Several other long term survivors have been described but only after radiotherapy or surgery. These findings suggest that systemic chemotherapy may be equally successful in treating isolated primary oesophageal lymphoma, thus offering an alternative for those patients in whom local treatment is contraindicated. (Gut 1993; 34: [994] [995] [996] [997] [998] Lymphomatous involvement of the oe wall is rare. According to published st mainly associated with Hodgkin's disease, where it has been reported in up to 6% of cases in postmortem studies; the incidence ofoesophageal invasion by non-Hodgkin's lymphoma does not exceed 1-6%. ' Tables I   and II summarise their main characteristics. As shown, recurrence of Hodgkin's disease, 10 or more years after initial treatment for this condition, was diagnosed in most cases. The nodular sclerosing form was the dominant histological sybtype, although this was not specified in all patients.
Isolated primary non-Hodgkin's lymphoma of the oesophagus seems to be exceptionally rare; in both reported cases, oesophageal lesions were the first manifestation of the disease. Presenting symptoms were not specific as neither patient initially complained of dysphagia.
An atypical presentation may contribute to a diagnostic delay, although this also occurred in patients with more specific symptoms. Diagnostic difficulties in those cases were related to confusing radiological and endoscopic appearances or failure to obtain histological confirmation of lymphoma.
A picture at barium swallow typical of malignancy, similar to that described in our case 2 patient, was only reported by Berman et al. '6 Other authors were confronted with a much more puzzling radiological picture, especially in early stages of the disease: a nodular aspect or Isolated primary oesophageal involvement by lymphoma: a rare cause ofdysphagia: two case histories and a review ofotherpublished data 1617 Negative endoscopic biopsies can, to some extent, be explained by the specific growth pattern of the tumour; primary lymphoma arises in submucosal lymphoid patches, hence not within easy reach of biopsy forceps. Accessibility may improve when the tumour grows towards the oesophageal lumen, but matters become more complicated when growth is primarily directed in the opposite direction, towards the surface. Fistula formation -for example to the trachea -may then be the first sign of the true nature of the disease.
Radiological and endoscopic appearances are mainly dependent on the presence of intraluminal lesions. Submucosal swelling may be localised, circumferential, or multifocal, resembling benign conditions like fibrotic strictures, leiomyoma, achalasia, or varices. Polyps or papillomatous lesions may develop as a result of pronounced local proliferation. Such lesions are by no means unique and similar patterns may be found when other parts of the gastrointestinal tract are affected by lymphoma. 5 Although difficult, an early diagnosis of primary oesophageal lymphoma seems to be vital as the response to treatment is often good. Table 2 shows that this is well documented for Hodgkin's disease. Four of the six patients survived five years; two of these four patients were still alive beyond that period, including our case 2 patient, the only long term survivor treated exclusively with combination chemotherapy.
Of the three patients that died, the cause of death was not mentioned in one case, a second patient died of oesophageal recurrence,8 the third succumbed to systemic lymphoma five years after irradiation of a single oesophageal manifestation; local treatment had been completely successful, as indicated at necropsy, which failed to reveal any signs of malignancy in the oesophagus.4 With the few data presently available, it is difficult to assess whether isolated primary involvement by non-Hodgkin's lymphoma would be equally responsive to treatment; our case 1 patient died of complications before any relevant treatment could be undertaken, whereas follow up in the case reported by Berman et 
